Matthew Hamilton Rosenberg’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Matthew Hamilton Rosenberg's VRTX Position: Q3 2026 in Review
Matthew Hamilton Rosenberg held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 184 shares worth $96.2K. The position accounts for 0.02% of the portfolio, ranked #357.
Matthew Hamilton Rosenberg first reported a position in VRTX in Q1 2020 and has held it in 27 quarters since. 478 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Matthew Hamilton Rosenberg held 184 shares of Vertex Pharmaceuticals worth $96.2K as of Q3 2026.
- Matthew Hamilton Rosenberg left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
- Vertex Pharmaceuticals made up 0.02% of Matthew Hamilton Rosenberg's portfolio in Q3 2026, its #357 holding.
- Matthew Hamilton Rosenberg first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 27 quarters since.
- 478 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2026, filed 5 Oct 2026.